Clinical trial
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment…
NCT00163111 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00163111 |
|---|---|
| Title | A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. |
| Official title | A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug |
| Interventions | VFEND® I.V., Oral, Conventional amphotericin B, Diflucan IV, oral |
| Enrollment | 412 |
| Start date | Sep 1, 1998 |
| Completion | May 1, 2003 |
| First posted | Sep 13, 2005 |
| Last update posted | Apr 26, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: